Fewer riders, dwindling cash and rising crime have America's largest mass-transit systems in a dilemma. an Alzheimer’s drug that has shown to modestly slow the early stages of the disease was approved by the FDA. What to make of Tesla's market downturn in 2022? Catch up on this week's Economics in the News. More
Encouraging employment report includes lower wages and less but healthy hiring. More
An unprecedented Arctic blast forced millions of Americans to alter or cancel holiday plans. Holiday sales climbed 7.6 percent. The NFL has a new partner for its Sunday Ticket package. Catch up on the latest Economics in the News. More
